Last updated on November 2017

Clinical trial for Patients with leukemia or lymphoma MI-CP204 (The Blood Cancer Study)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Blood Cancer
  • Age: 18 Years
  • Gender: Male or Female
  • Other:
    • Subjects must have been diagnosed with one of the following B-cell malignancies that has returned after treatment, or has not responded to treatment: 1. chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) 2. aggressive lymphoma: diffuse large B-cell lymphoma (DLBCL), advanced grade follicular lymphoma (FL), FL transforming to DLBCL, transformed indolent lymphoma, or mantle cell lymphoma
    • Subjects must have previously received chemotherapy in combination with rituximab or an anti-CD20 agent to treat B-cell malignancy.
    • Subjects must not remove

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.